7 BlackRock Oruka Therapeutics Trades
BlackRock's position in Oruka Therapeutics is currently worth $220M. That's 0.00% of their equity portfolio (1611th largest holding). The investor owns 10.02% of the outstanding Oruka Therapeutics stock. The first Oruka Therapeutics trade was made in Q3 2024. Since then BlackRock bought shares four more times and sold shares on two occasions. The stake costed the investor $69.9M, netting the investor a gain of 214% so far.
News about Oruka Therapeutics, Inc. and BlackRock
Why Are Hedge Funds Shorting ARCA Biopharma, Inc. (ABIO)?
We recently compiled a list of What Is Short Selling In Stock Market? 15 Stocks Hedge Funds are Shorting. In this article, we are going to take a look at whe...
Shareholder Alert: Ademi LLP investigates Disclosure Issues involving ARCA biopharma, Inc.'s Transaction with Oruka
MILWAUKEE , June 4, 2024 /PRNewswire/ -- Ademi LLP is investigating ARCA (NASDAQ: ABIO) for possible breaches of fiduciary duty and other violations of law i...
3 Short-Squeeze Stocks Ready to Soar on Roaring Kitty Rally
Yesterday, the forgotten meme stocks of 2021 started picking up serious momentum. But unlike 2021, it didn’t take much to see the reason behind GameStop’s (N...
3 Short-Squeeze Stocks Ready to Soar on Roaring Kitty Rally
Yesterday, the forgotten meme stocks of 2021 started picking up serious momentum. But unlike 2021, it didn't take much to see the reason behind GameStop's (N...